オシメルチニブメシル酸塩APIのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Osimertinib Mesylate API Market Insights and Forecast to 2027

• レポートコード：QY2112C00713
• 出版社/出版日：QYResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査資料はオシメルチニブメシル酸塩APIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。オシメルチニブメシル酸塩APIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99.0％以上、その他）、用途別市場規模（転移性非小細胞肺がん、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・オシメルチニブメシル酸塩APIの世界市場概要
・メーカー別の競争状況、市場シェア
・オシメルチニブメシル酸塩APIの種類別市場規模：純度99.0％以上、その他
・オシメルチニブメシル酸塩APIの用途別市場規模：転移性非小細胞肺がん、その他
・北米のオシメルチニブメシル酸塩API市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ）
・ヨーロッパのオシメルチニブメシル酸塩API市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス）
・アジアのオシメルチニブメシル酸塩API市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国）
・中南米のオシメルチニブメシル酸塩API市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル）
・中東・アフリカのオシメルチニブメシル酸塩API市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア）
・企業情報：Teva api、Daicel Chiral Technologies、Transo-Pharm
・オシメルチニブメシル酸塩APIのバリューチェーン・販売チャネル分析
・オシメルチニブメシル酸塩APIの世界市場動向

Market Analysis and Insights: Global Osimertinib Mesylate API Market
The global Osimertinib Mesylate API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Osimertinib Mesylate API Scope and Segment
Osimertinib Mesylate API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osimertinib Mesylate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 99.0％
Other

Segment by Application
Metastatic Non-small-cell Lung Cancer
Other

By Company
Teva api
Daicel Chiral Technologies
Transo-Pharm

Production by Region
North America
Europe
China
India

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Osimertinib Mesylate API Product Introduction
1.2 Market by Type
1.2.1 Global Osimertinib Mesylate API Market Size Growth Rate by Type
1.2.2 Purity ≥ 99.0％
1.2.3 Other
1.3 Market by Application
1.3.1 Global Osimertinib Mesylate API Market Size Growth Rate by Application
1.3.2 Metastatic Non-small-cell Lung Cancer
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Osimertinib Mesylate API Production
2.1 Global Osimertinib Mesylate API Production Capacity (2016-2027)
2.2 Global Osimertinib Mesylate API Production by Region: 2016 VS 2021 VS 2027
2.3 Global Osimertinib Mesylate API Production by Region
2.3.1 Global Osimertinib Mesylate API Historic Production by Region (2016-2021)
2.3.2 Global Osimertinib Mesylate API Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 India

3 Global Osimertinib Mesylate API Sales in Volume & Value Estimates and Forecasts
3.1 Global Osimertinib Mesylate API Sales Estimates and Forecasts 2016-2027
3.2 Global Osimertinib Mesylate API Revenue Estimates and Forecasts 2016-2027
3.3 Global Osimertinib Mesylate API Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Osimertinib Mesylate API Regions by Sales
3.4.1 Global Top Osimertinib Mesylate API Regions by Sales (2016-2021)
3.4.2 Global Top Osimertinib Mesylate API Regions by Sales (2022-2027)
3.5 Global Top Osimertinib Mesylate API Regions by Revenue
3.5.1 Global Top Osimertinib Mesylate API Regions by Revenue (2016-2021)
3.5.2 Global Top Osimertinib Mesylate API Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Osimertinib Mesylate API Production Capacity by Manufacturers
4.2 Global Osimertinib Mesylate API Sales by Manufacturers
4.2.1 Global Top Osimertinib Mesylate API Manufacturers by Sales (2016-2021)
4.2.2 Global Top Osimertinib Mesylate API Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Osimertinib Mesylate API Sales in 2020
4.3 Global Osimertinib Mesylate API Revenue by Manufacturers
4.3.1 Global Top Osimertinib Mesylate API Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Osimertinib Mesylate API Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Osimertinib Mesylate API Revenue in 2020
4.4 Global Osimertinib Mesylate API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Osimertinib Mesylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Osimertinib Mesylate API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Osimertinib Mesylate API Sales by Type
5.1.1 Global Osimertinib Mesylate API Historical Sales by Type (2016-2021)
5.1.2 Global Osimertinib Mesylate API Forecasted Sales by Type (2022-2027)
5.1.3 Global Osimertinib Mesylate API Sales Market Share by Type (2016-2027)
5.2 Global Osimertinib Mesylate API Revenue by Type
5.2.1 Global Osimertinib Mesylate API Historical Revenue by Type (2016-2021)
5.2.2 Global Osimertinib Mesylate API Forecasted Revenue by Type (2022-2027)
5.2.3 Global Osimertinib Mesylate API Revenue Market Share by Type (2016-2027)
5.3 Global Osimertinib Mesylate API Price by Type
5.3.1 Global Osimertinib Mesylate API Price by Type (2016-2021)
5.3.2 Global Osimertinib Mesylate API Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global Osimertinib Mesylate API Sales by Application
6.1.1 Global Osimertinib Mesylate API Historical Sales by Application (2016-2021)
6.1.2 Global Osimertinib Mesylate API Forecasted Sales by Application (2022-2027)
6.1.3 Global Osimertinib Mesylate API Sales Market Share by Application (2016-2027)
6.2 Global Osimertinib Mesylate API Revenue by Application
6.2.1 Global Osimertinib Mesylate API Historical Revenue by Application (2016-2021)
6.2.2 Global Osimertinib Mesylate API Forecasted Revenue by Application (2022-2027)
6.2.3 Global Osimertinib Mesylate API Revenue Market Share by Application (2016-2027)
6.3 Global Osimertinib Mesylate API Price by Application
6.3.1 Global Osimertinib Mesylate API Price by Application (2016-2021)
6.3.2 Global Osimertinib Mesylate API Price Forecast by Application (2022-2027)

7 North America
7.1 North America Osimertinib Mesylate API Market Size by Type
7.1.1 North America Osimertinib Mesylate API Sales by Type (2016-2027)
7.1.2 North America Osimertinib Mesylate API Revenue by Type (2016-2027)
7.2 North America Osimertinib Mesylate API Market Size by Application
7.2.1 North America Osimertinib Mesylate API Sales by Application (2016-2027)
7.2.2 North America Osimertinib Mesylate API Revenue by Application (2016-2027)
7.3 North America Osimertinib Mesylate API Sales by Country
7.3.1 North America Osimertinib Mesylate API Sales by Country (2016-2027)
7.3.2 North America Osimertinib Mesylate API Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Osimertinib Mesylate API Market Size by Type
8.1.1 Europe Osimertinib Mesylate API Sales by Type (2016-2027)
8.1.2 Europe Osimertinib Mesylate API Revenue by Type (2016-2027)
8.2 Europe Osimertinib Mesylate API Market Size by Application
8.2.1 Europe Osimertinib Mesylate API Sales by Application (2016-2027)
8.2.2 Europe Osimertinib Mesylate API Revenue by Application (2016-2027)
8.3 Europe Osimertinib Mesylate API Sales by Country
8.3.1 Europe Osimertinib Mesylate API Sales by Country (2016-2027)
8.3.2 Europe Osimertinib Mesylate API Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Osimertinib Mesylate API Market Size by Type
9.1.1 Asia Pacific Osimertinib Mesylate API Sales by Type (2016-2027)
9.1.2 Asia Pacific Osimertinib Mesylate API Revenue by Type (2016-2027)
9.2 Asia Pacific Osimertinib Mesylate API Market Size by Application
9.2.1 Asia Pacific Osimertinib Mesylate API Sales by Application (2016-2027)
9.2.2 Asia Pacific Osimertinib Mesylate API Revenue by Application (2016-2027)
9.3 Asia Pacific Osimertinib Mesylate API Sales by Region
9.3.1 Asia Pacific Osimertinib Mesylate API Sales by Region (2016-2027)
9.3.2 Asia Pacific Osimertinib Mesylate API Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Osimertinib Mesylate API Market Size by Type
10.1.1 Latin America Osimertinib Mesylate API Sales by Type (2016-2027)
10.1.2 Latin America Osimertinib Mesylate API Revenue by Type (2016-2027)
10.2 Latin America Osimertinib Mesylate API Market Size by Application
10.2.1 Latin America Osimertinib Mesylate API Sales by Application (2016-2027)
10.2.2 Latin America Osimertinib Mesylate API Revenue by Application (2016-2027)
10.3 Latin America Osimertinib Mesylate API Sales by Country
10.3.1 Latin America Osimertinib Mesylate API Sales by Country (2016-2027)
10.3.2 Latin America Osimertinib Mesylate API Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Osimertinib Mesylate API Market Size by Type
11.1.1 Middle East and Africa Osimertinib Mesylate API Sales by Type (2016-2027)
11.1.2 Middle East and Africa Osimertinib Mesylate API Revenue by Type (2016-2027)
11.2 Middle East and Africa Osimertinib Mesylate API Market Size by Application
11.2.1 Middle East and Africa Osimertinib Mesylate API Sales by Application (2016-2027)
11.2.2 Middle East and Africa Osimertinib Mesylate API Revenue by Application (2016-2027)
11.3 Middle East and Africa Osimertinib Mesylate API Sales by Country
11.3.1 Middle East and Africa Osimertinib Mesylate API Sales by Country (2016-2027)
11.3.2 Middle East and Africa Osimertinib Mesylate API Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Teva api
12.1.1 Teva api Corporation Information
12.1.2 Teva api Overview
12.1.3 Teva api Osimertinib Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Teva api Osimertinib Mesylate API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Teva api Recent Developments
12.2 Daicel Chiral Technologies
12.2.1 Daicel Chiral Technologies Corporation Information
12.2.2 Daicel Chiral Technologies Overview
12.2.3 Daicel Chiral Technologies Osimertinib Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Daicel Chiral Technologies Osimertinib Mesylate API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Daicel Chiral Technologies Recent Developments
12.3 Transo-Pharm
12.3.1 Transo-Pharm Corporation Information
12.3.2 Transo-Pharm Overview
12.3.3 Transo-Pharm Osimertinib Mesylate API Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Transo-Pharm Osimertinib Mesylate API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Transo-Pharm Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Osimertinib Mesylate API Industry Chain Analysis
13.2 Osimertinib Mesylate API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Osimertinib Mesylate API Production Mode & Process
13.4 Osimertinib Mesylate API Sales and Marketing
13.4.1 Osimertinib Mesylate API Sales Channels
13.4.2 Osimertinib Mesylate API Distributors
13.5 Osimertinib Mesylate API Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Osimertinib Mesylate API Industry Trends
14.2 Osimertinib Mesylate API Market Drivers
14.3 Osimertinib Mesylate API Market Challenges
14.4 Osimertinib Mesylate API Market Restraints

15 Key Finding in The Global Osimertinib Mesylate API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Osimertinib Mesylate API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity ≥ 99.0％
Table 3. Major Manufacturers of Other
Table 4. Global Osimertinib Mesylate API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Osimertinib Mesylate API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Osimertinib Mesylate API Production by Region (2016-2021) & (Ton)
Table 7. Global Osimertinib Mesylate API Production Market Share by Region (2016-2021)
Table 8. Global Osimertinib Mesylate API Production by Region (2022-2027) & (Ton)
Table 9. Global Osimertinib Mesylate API Production Market Share by Region (2022-2027)
Table 10. Global Osimertinib Mesylate API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Osimertinib Mesylate API Sales by Region (2016-2021) & (Ton)
Table 12. Global Osimertinib Mesylate API Sales Market Share by Region (2016-2021)
Table 13. Global Osimertinib Mesylate API Sales by Region (2022-2027) & (Ton)
Table 14. Global Osimertinib Mesylate API Sales Market Share by Region (2022-2027)
Table 15. Global Osimertinib Mesylate API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Osimertinib Mesylate API Revenue Market Share by Region (2016-2021)
Table 17. Global Osimertinib Mesylate API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Osimertinib Mesylate API Revenue Market Share by Region (2022-2027)
Table 19. Global Osimertinib Mesylate API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Osimertinib Mesylate API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Osimertinib Mesylate API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Osimertinib Mesylate API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Osimertinib Mesylate API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Osimertinib Mesylate API Sales Share by Manufacturers (2016-2021)
Table 25. Global Osimertinib Mesylate API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Osimertinib Mesylate API Revenue Share by Manufacturers (2016-2021)
Table 27. Osimertinib Mesylate API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Osimertinib Mesylate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Osimertinib Mesylate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osimertinib Mesylate API as of 2020)
Table 30. Osimertinib Mesylate API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Osimertinib Mesylate API Product Offered
Table 32. Date of Manufacturers Enter into Osimertinib Mesylate API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Osimertinib Mesylate API Sales by Type (2016-2021) & (Ton)
Table 35. Global Osimertinib Mesylate API Sales by Type (2022-2027) & (Ton)
Table 36. Global Osimertinib Mesylate API Sales Share by Type (2016-2021)
Table 37. Global Osimertinib Mesylate API Sales Share by Type (2022-2027)
Table 38. Global Osimertinib Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Osimertinib Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Osimertinib Mesylate API Revenue Share by Type (2016-2021)
Table 41. Global Osimertinib Mesylate API Revenue Share by Type (2022-2027)
Table 42. Osimertinib Mesylate API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Osimertinib Mesylate API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Osimertinib Mesylate API Sales by Application (2016-2021) & (Ton)
Table 45. Global Osimertinib Mesylate API Sales by Application (2022-2027) & (Ton)
Table 46. Global Osimertinib Mesylate API Sales Share by Application (2016-2021)
Table 47. Global Osimertinib Mesylate API Sales Share by Application (2022-2027)
Table 48. Global Osimertinib Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Osimertinib Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Osimertinib Mesylate API Revenue Share by Application (2016-2021)
Table 51. Global Osimertinib Mesylate API Revenue Share by Application (2022-2027)
Table 52. Osimertinib Mesylate API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Osimertinib Mesylate API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Osimertinib Mesylate API Sales by Type (2016-2021) & (Ton)
Table 55. North America Osimertinib Mesylate API Sales by Type (2022-2027) & (Ton)
Table 56. North America Osimertinib Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Osimertinib Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Osimertinib Mesylate API Sales by Application (2016-2021) & (Ton)
Table 59. North America Osimertinib Mesylate API Sales by Application (2022-2027) & (Ton)
Table 60. North America Osimertinib Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Osimertinib Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Osimertinib Mesylate API Sales by Country (2016-2021) & (Ton)
Table 63. North America Osimertinib Mesylate API Sales by Country (2022-2027) & (Ton)
Table 64. North America Osimertinib Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Osimertinib Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Osimertinib Mesylate API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Osimertinib Mesylate API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Osimertinib Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Osimertinib Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Osimertinib Mesylate API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Osimertinib Mesylate API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Osimertinib Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Osimertinib Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Osimertinib Mesylate API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Osimertinib Mesylate API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Osimertinib Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Osimertinib Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Osimertinib Mesylate API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Osimertinib Mesylate API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Osimertinib Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Osimertinib Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Osimertinib Mesylate API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Osimertinib Mesylate API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Osimertinib Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Osimertinib Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Osimertinib Mesylate API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Osimertinib Mesylate API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Osimertinib Mesylate API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Osimertinib Mesylate API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Osimertinib Mesylate API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Osimertinib Mesylate API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Osimertinib Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Osimertinib Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Osimertinib Mesylate API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Osimertinib Mesylate API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Osimertinib Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Osimertinib Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Osimertinib Mesylate API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Osimertinib Mesylate API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Osimertinib Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Osimertinib Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Osimertinib Mesylate API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Osimertinib Mesylate API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Osimertinib Mesylate API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Osimertinib Mesylate API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Osimertinib Mesylate API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Osimertinib Mesylate API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Osimertinib Mesylate API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Osimertinib Mesylate API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Osimertinib Mesylate API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Osimertinib Mesylate API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Osimertinib Mesylate API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Osimertinib Mesylate API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Teva api Corporation Information
Table 115. Teva api Description and Major Businesses
Table 116. Teva api Osimertinib Mesylate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Teva api Osimertinib Mesylate API Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Teva api Recent Development
Table 119. Daicel Chiral Technologies Corporation Information
Table 120. Daicel Chiral Technologies Description and Major Businesses
Table 121. Daicel Chiral Technologies Osimertinib Mesylate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Daicel Chiral Technologies Osimertinib Mesylate API Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Daicel Chiral Technologies Recent Development
Table 124. Transo-Pharm Corporation Information
Table 125. Transo-Pharm Description and Major Businesses
Table 126. Transo-Pharm Osimertinib Mesylate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Transo-Pharm Osimertinib Mesylate API Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Transo-Pharm Recent Development
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Osimertinib Mesylate API Distributors List
Table 132. Osimertinib Mesylate API Customers List
Table 133. Osimertinib Mesylate API Market Trends
Table 134. Osimertinib Mesylate API Market Drivers
Table 135. Osimertinib Mesylate API Market Challenges
Table 136. Osimertinib Mesylate API Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Osimertinib Mesylate API Product Picture
Figure 2. Global Osimertinib Mesylate API Market Share by Type in 2020 & 2027
Figure 3. Purity ≥ 99.0％ Product Picture
Figure 4. Other Product Picture
Figure 5. Global Osimertinib Mesylate API Market Share by Application in 2020 & 2027
Figure 6. Metastatic Non-small-cell Lung Cancer
Figure 7. Other
Figure 8. Osimertinib Mesylate API Report Years Considered
Figure 9. Global Osimertinib Mesylate API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Osimertinib Mesylate API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Osimertinib Mesylate API Production Market Share by Region (2016-2021)
Figure 12. Global Osimertinib Mesylate API Production Market Share by Region (2022-2027)
Figure 13. Osimertinib Mesylate API Production Growth Rate in North America (2016-2027) & (Ton)
Figure 14. Osimertinib Mesylate API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Osimertinib Mesylate API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Osimertinib Mesylate API Production Growth Rate in India (2016-2027) & (Ton)
Figure 17. Global Osimertinib Mesylate API Sales 2016-2027 (Ton)
Figure 18. Global Osimertinib Mesylate API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Osimertinib Mesylate API Revenue 2016-2027 (US$ Million)
Figure 20. Global Osimertinib Mesylate API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Osimertinib Mesylate API Sales Market Share by Region (2016-2021)
Figure 22. Global Osimertinib Mesylate API Sales Market Share by Region (2022-2027)
Figure 23. North America Osimertinib Mesylate API Sales YoY (2016-2027) & (Ton)
Figure 24. North America Osimertinib Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Osimertinib Mesylate API Sales YoY (2016-2027) & (Ton)
Figure 26. Europe Osimertinib Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Osimertinib Mesylate API Sales YoY (2016-2027) & (Ton)
Figure 28. Asia-Pacific Osimertinib Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Osimertinib Mesylate API Sales YoY (2016-2027) & (Ton)
Figure 30. Latin America Osimertinib Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Osimertinib Mesylate API Sales YoY (2016-2027) & (Ton)
Figure 32. Middle East & Africa Osimertinib Mesylate API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Osimertinib Mesylate API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Osimertinib Mesylate API Revenue in 2020
Figure 35. Osimertinib Mesylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Osimertinib Mesylate API Sales Market Share by Type (2016-2027)
Figure 37. Global Osimertinib Mesylate API Revenue Market Share by Type (2016-2027)
Figure 38. Global Osimertinib Mesylate API Sales Market Share by Application (2016-2027)
Figure 39. Global Osimertinib Mesylate API Revenue Market Share by Application (2016-2027)
Figure 40. North America Osimertinib Mesylate API Sales Market Share by Type (2016-2027)
Figure 41. North America Osimertinib Mesylate API Revenue Market Share by Type (2016-2027)
Figure 42. North America Osimertinib Mesylate API Sales Market Share by Application (2016-2027)
Figure 43. North America Osimertinib Mesylate API Revenue Market Share by Application (2016-2027)
Figure 44. North America Osimertinib Mesylate API Sales Share by Country (2016-2027)
Figure 45. North America Osimertinib Mesylate API Revenue Share by Country (2016-2027)
Figure 46. United States Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Osimertinib Mesylate API Sales Market Share by Type (2016-2027)
Figure 49. Europe Osimertinib Mesylate API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Osimertinib Mesylate API Sales Market Share by Application (2016-2027)
Figure 51. Europe Osimertinib Mesylate API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Osimertinib Mesylate API Sales Share by Country (2016-2027)
Figure 53. Europe Osimertinib Mesylate API Revenue Share by Country (2016-2027)
Figure 54. Germany Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 55. France Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Osimertinib Mesylate API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Osimertinib Mesylate API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Osimertinib Mesylate API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Osimertinib Mesylate API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Osimertinib Mesylate API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Osimertinib Mesylate API Revenue Share by Region (2016-2027)
Figure 65. China Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 68. India Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Osimertinib Mesylate API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Osimertinib Mesylate API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Osimertinib Mesylate API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Osimertinib Mesylate API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Osimertinib Mesylate API Sales Share by Country (2016-2027)
Figure 79. Latin America Osimertinib Mesylate API Revenue Share by Country (2016-2027)
Figure 80. Mexico Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Osimertinib Mesylate API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Osimertinib Mesylate API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Osimertinib Mesylate API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Osimertinib Mesylate API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Osimertinib Mesylate API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Osimertinib Mesylate API Revenue Share by Country (2016-2027)
Figure 89. Turkey Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Osimertinib Mesylate API Revenue (2016-2027) & (US$ Million)
Figure 92. Osimertinib Mesylate API Value Chain
Figure 93. Osimertinib Mesylate API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

Global Pefloxacin Mesylate Market Insights and Forecast to 2027
QY2112C03902 2021年12月 100Pages
本調査資料はペフロキサシン·メタンスルホン酸の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ペフロキサシン·メタンスルホン酸の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（タブレット、カプセル、注射）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域...

ナファゾリン硝酸塩のグローバル市場インサイト・予測（～2027年）

Global Naphazoline Nitrate Market Insights and Forecast to 2027
QY2112C00556 2021年12月 126Pages
本調査資料はナファゾリン硝酸塩の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ナファゾリン硝酸塩の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（98％以下、98％〜99％、99％以上）、用途別市場規模（バイオ医薬品、実験室、その他）、主要地域別市場規模（北...

フタロ顔料のグローバル市場インサイト・予測（～2027年）

Global Phthalo Pigment Market Insights and Forecast to 2027
QY2112C00820 2021年12月 126Pages
本調査資料はフタロ顔料の世界市場の現状について調査・分析し、2027年までの市場を予測しました。フタロ顔料の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（フタロブルー、フタログリーン）、用途別市場規模（塗料・コーティング剤、インク、プラスチック、その他）、主要地域別市場規模（北米・...

プラスチック包装袋のグローバル市場インサイト・予測（～2027年）

Global Plastic Packaging Bags Market Insights and Forecast to 2027
QY2112C00838 2021年12月 129Pages
本調査資料はプラスチック包装袋の世界市場の現状について調査・分析し、2027年までの市場を予測しました。プラスチック包装袋の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（PP、PE、その他）、用途別市場規模（食品産業、化学、農業、製薬、パーソナル＆ホームケア、その他）、主要地域別市...

液体リン酸塩のグローバル市場インサイト・予測（～2027年）

Global Liquid Phosphites Market Insights and Forecast to 2027
QY2112C00332 2021年12月 96Pages
本調査資料は液体リン酸塩の世界市場の現状について調査・分析し、2027年までの市場を予測しました。液体リン酸塩の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（DPDP、EHDP、PDDP、TNPP）、用途別市場規模（熱安定剤、酸化防止剤、その他）、主要地域別市場規模（北米・アメリカ...

ヨウ化銀のグローバル市場インサイト・予測（～2027年）

Global Silver Iodide Market Insights and Forecast to 2027
QY2112C01189 2021年12月 99Pages
本調査資料はヨウ化銀の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ヨウ化銀の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.9％、純度99.99％、純度99.999％）、用途別市場規模（写真、実験室、その他）、主要地域別市場規模（北米...

ジュエリー用電気メッキ薬品のグローバル市場インサイト・予測（～2027年）

Global Jewelry Electroplating Chemical Market Insights and Forecast to 2027
QY2112C00256 2021年12月 100Pages
本調査資料はジュエリー用電気メッキ薬品の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ジュエリー用電気メッキ薬品の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（前処理剤、電気メッキ添加剤、後処理剤）、用途別市場規模（金メッキ、銀メッキ）、主要地域別市場規模...

硝酸スカンジウムのグローバル市場インサイト・予測（～2027年）

Global Scandium Nitrate Market Insights and Forecast to 2027
QY2112C01101 2021年12月 104Pages
本調査資料は硝酸スカンジウムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。硝酸スカンジウムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.9％、純度99.99％、純度99.999％）、用途別市場規模（化学、実験室、工業、その他）、主...

テルル化モリブデンスパッタリングターゲットのグローバル市場インサイト・予測（～2027年）

Global Molybdenum Telluride Sputtering Target Market Insights and Forecast to 2027
QY2112C00525 2021年12月 109Pages
本調査資料はテルル化モリブデンスパッタリングターゲットの世界市場の現状について調査・分析し、2027年までの市場を予測しました。テルル化モリブデンスパッタリングターゲットの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.5％、純度99.9％、純度99.95％、純...

金属検出可能型シリコーンシートのグローバル市場インサイト・予測（～2027年）

Global Metal Detectable Silicone Sheets Market Insights and Forecast to 2027
QY2112C00442 2021年12月 127Pages
本調査資料は金属検出可能型シリコーンシートの世界市場の現状について調査・分析し、2027年までの市場を予測しました。金属検出可能型シリコーンシートの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（固体シリコーン、スポンジシリコーン）、用途別市場規模（食品・飲料、医薬品、その他）、主要...

ペフロキサシン·メタンスルホン酸のグローバル市場インサイト・予測（～2027年） Pefloxacin Mesylate is a quinolone antibacterial drug that can treat various infections caused by pefloxacin-sensitive bacteria, such as urinary tract infections and respiratory tract infections. Market Analysis and Insights: Global Pefloxacin Mesylate Market The global Pefloxacin Mesylate market is…
スモールセルアンテナのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Small Cell Antennas Market The global Small Cell Antennas market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Small Cell Antennas Scope and Segment Small Cell …
腫瘍・抗がん剤のグローバル市場インサイト・予測（～2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors…
前立腺がん治療装置のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Prostate Cancer Treatment Device Market The global Prostate Cancer Treatment Device market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Prostate Cancer Treatment Devic…
水素燃料電池エンジンのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Hydrogen Fuel Cell Engine Market The global Hydrogen Fuel Cell Engine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Hydrogen Fuel Cell Engine Scope and S…